We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRZO
1001
DELISTED
Carrizo Oil & Gas Inc
CRZO
$1.04M 0.01%
37,509
GBT
1002
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.04M 0.01%
23,097
+5,516
+31% +$251K
NVRO
1003
DELISTED
NEVRO CORP.
NVRO
$1.04M 0.01%
13,030
ARI
1004
Apollo Commercial Real Estate
ARI
$885M
$1.04M 0.01%
56,688
+7,260
+15% +$133K
EBS icon
1005
Emergent Biosolutions
EBS
$233M
$1.04M 0.01%
20,512
+4,795
+31% +$250K
SBGI icon
1006
Sinclair Inc
SBGI
$1B
$1.03M 0.01%
31,990
FCN icon
1007
FTI Consulting
FCN
$4.22B
$1.02M 0.01%
16,848
RNST icon
1008
Renasant Corp
RNST
$3.96B
$1.01M 0.01%
22,158
+2,071
+10% +$96.3K
MGEE icon
1009
MGE Energy Inc
MGEE
$3.07B
$1.01M 0.01%
15,960
+951
+6% +$55.4K
QDEL icon
1010
QuidelOrtho
QDEL
$1.02B
$1.01M 0.01%
15,132
+1,229
+9% +$74.3K
ORA icon
1011
Ormat Technologies
ORA
$6.97B
$1M 0.01%
18,869
AEIS icon
1012
Advanced Energy
AEIS
$13.5B
$1M 0.01%
17,261
ROIC
1013
DELISTED
Retail Opportunity Investments Corp.
ROIC
$1M 0.01%
52,344
INDB icon
1014
Independent Bank
INDB
$4.04B
$1M 0.01%
12,760
CLVS
1015
DELISTED
Clovis Oncology, Inc.
CLVS
$999K 0.01%
21,967
+1,764
+9% +$85.8K
WTS icon
1016
Watts Water Technologies
WTS
$12.9B
$997K 0.01%
12,721
+914
+8% +$70.9K
LAD icon
1017
Lithia Motors
LAD
$8.32B
$995K 0.01%
10,519
TEN
1018
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$994K 0.01%
22,605
OMCL icon
1019
Omnicell
OMCL
$1.69B
$991K 0.01%
18,897
+2,151
+13% +$101K
ITGR icon
1020
Integer Holdings
ITGR
$4.25B
$988K 0.01%
15,275
SLCA
1021
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$985K 0.01%
38,361
POWI icon
1022
Power Integrations
POWI
$3.57B
$984K 0.01%
26,942
ARNA
1023
DELISTED
Arena Pharmaceuticals Inc
ARNA
$981K 0.01%
22,490
DNR
1024
DELISTED
Denbury Resources, Inc.
DNR
$980K 0.01%
203,761
+13,424
+7% +$50.3K
ABCB icon
1025
Ameris Bancorp
ABCB
$5.94B
$978K 0.01%
18,334
+1,479
+9% +$80.8K

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.